UK Accelerated Access Proposals Due Out Soon
UK proposals to promote innovation and speed access to promising new drugs could among other things prompt new payment models. The final report on the government’s Accelerated Access Review should be out by the end of the month.
You may also be interested in...
The UK government’s response to the Accelerated Access Review report is on hold until after the snap general election in June.
A new fund is expected to help remove uncertainties around the financing of new treatments in the future. It introduces new timelines for health boards to ensure that innovative medicines approved by NICE or the Welsh AWMSG are made available faster to eligible patients on the NHS.
The UK's early access to medicines scheme (EAMS) has been operational for two years, along with a "promising innovative medicine" (PIM) designation, to give patients timely access to new drugs for serious diseases before they are approved. The system has now been independently reviewed. Sten Stovall talks to those in the industry that have first-hand experience of the process.